New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lanreotide acetate 149.4mg equivalent to lanreotide 120 mg - solution for injection - 120 mg - active: lanreotide acetate 149.4mg equivalent to lanreotide 120 mg excipient: glacial acetic acid water for injection - treatment of acromegaly when circulating levels of gh and igf-1 remain abnormal after surgery and/or radiotherapy, or in patients who are dopamine agonist treatment refractory. treatment of symptoms of carcinoid syndrome associated with carcinoid tumours. the treatment of well or moderately differentiated gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lanreotide acetate 77.9mg equivalent to lanreotide 60 mg - solution for injection - 60 mg - active: lanreotide acetate 77.9mg equivalent to lanreotide 60 mg excipient: glacial acetic acid water for injection - treatment of acromegaly when circulating levels of gh and igf-1 remain abnormal after surgery and/or radiotherapy, or in patients who are dopamine agonist treatment refractory. treatment of symptoms of carcinoid syndrome associated with carcinoid tumours. the treatment of well or moderately differentiated gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lanreotide acetate 113.6mg equivalent to lanreotide 90 mg - solution for injection - 90 mg - active: lanreotide acetate 113.6mg equivalent to lanreotide 90 mg excipient: glacial acetic acid water for injection - treatment of acromegaly when circulating levels of gh and igf-1 remain abnormal after surgery and/or radiotherapy, or in patients who are dopamine agonist treatment refractory. treatment of symptoms of carcinoid syndrome associated with carcinoid tumours. the treatment of well or moderately differentiated gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ferrer international - citicoline (citicoline sodium) - solution for injection - 250mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ferrer international - citicoline (citicoline sodium) - solution oral - 100mg/ml

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - lanreotide acetate 149.4mg eqv lanreotide - injection, solution - 120 mg - lanreotide acetate 149.4mg eqv lanreotide 120 mg

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - lanreotide acetate 77.9mg eqv lanreotide - injection, solution - 60 mg - lanreotide acetate 77.9mg eqv lanreotide 60 mg

Singapore - English - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - lanreotide acetate 113.6mg eqv lanreotide - injection, solution - 90 mg - lanreotide acetate 113.6mg eqv lanreotide 90 mg

Malta - English - Medicines Authority

ferrer internacional s.a. gran vía carlos iii, 94 08028 barcelona, spain - citicoline - oral solution - citicoline 100 mg/ml - psychoanaleptics

Israel - English - Ministry of Health

medison pharma ltd - lanreotide acetate - powder and solvent for suspension for injection - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.